Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosisErika Resetkova
Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Semin Oncol 35:25-32. 2008
..The focus of this chapter is on the histomorphologic characteristics of IBC and its broad differential diagnosis...
Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservationErika Resetkova
Department of Pathology, New York Presbyterian Hospital Weill Cornell Center, New York, NY 10021, USA
Arch Pathol Lab Med 127:77-80. 2003
..We report here the unique 10-year follow-up of a woman who underwent breast conservation treatment for carcinoma that arose in microglandular adenosis...
- Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey
Fernando Schuh
Pós Graduação em Ciências Médicas, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul UFRGS, Porto Alegre, Brazil
Pathol Res Pract 206:705-11. 2010
..Comparing the three classification systems, diagnostic agreement and accuracy were rated higher for the classification of Van Nuys compared to modified Lagios and Holland...
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
Erika Resetkova
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 46202, USA
Breast Cancer Res Treat 123:97-108. 2010
..The novel finding is that tumor microenvironment may play a significant role in determining the prognostic impact of stem/progenitor cells in human breast tumors...
- Loss of annexin A1 expression in breast cancer progression
Ying Cao
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Appl Immunohistochem Mol Morphol 16:530-4. 2008
..Therefore, to accurately characterize the ANXA1 expression pattern, we used microarray analysis and matched patient samples to evaluate progressive alterations in ANXA1 protein expression during malignant transformation and metastasis...
- Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma
Sumita Gokhale
Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Appl Immunohistochem Mol Morphol 15:451-5. 2007
..In 4 of these, the percentage of cells staining for ER was low (0% to 20%). Overall, the 2 systems were comparable, and discrepant results were most frequently seen when analyzing tumors with low levels of ER positive cells...
- Giant cell tumor of soft tissue arising in breast
Steve A May
Department of Pathology, Unit 085, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
Ann Diagn Pathol 11:345-9. 2007
..To our knowledge, this is the first case report of a GCT-ST arising in the breast associated with a fatal outcome. The distinction of this entity from other more common primary breast tumors with giant cell morphology is also emphasized...
- Primary osteosarcoma of the breast: report of 2 cases
Armita Bahrami
Department of Pathology, Baylor College of Medicine, Houston, TX, USA
Arch Pathol Lab Med 131:792-5. 2007
....
- A large, fungating breast mass. Secretory carcinoma with apocrine differentiation
Paula Anderson
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Arch Pathol Lab Med 130:e50-2. 2006
- Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature
Erika Resetkova
Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Am J Surg Pathol 30:20-7. 2006
..Caution is needed not to overinterpret collagenous spherulosis as atypical or ductal carcinoma in situ, especially on core needle biopsy specimens...
- Images in pathology. Mammary crystalloids
Erika Resetkova
Department of Pathology New York Presbyterian Hospital-Weill, Medical College of Cornell University, New York, USA
Int J Surg Pathol 10:148. 2002
- Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions
Syed A Hoda
Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10021, USA
Microsc Res Tech 59:85-91. 2002
....
- Breast carcinoma with choriocarcinomatous features
Erika Resetkova
Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Ann Diagn Pathol 8:74-9. 2004
..Immunostaining for the beta subunit of human chorionic gonadotropin was localized mostly, but not entirely, to multinucleated syncytiotrophoblast-like giant cells within both tumors...
- Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma
Erika Resetkova
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
Cancer 101:913-7. 2004
..CONCLUSIONS: Expression of P53 and MUC-1 may be predictive of treatment efficacy and outcome for patients with IBC. Furthermore, these two markers may represent novel therapeutic targets in such patients...
- Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma
Erika Resetkova
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Arch Pathol Lab Med 129:e79-80. 2005
- Megakaryocytes mimicking metastatic breast carcinoma
Syed A Hoda
Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital Weill Cornell Medical Center, New York, NY 10021, USA
Arch Pathol Lab Med 126:618-20. 2002
..Megakaryocytes should be added to the list of benign histologic abnormalities that may simulate metastatic carcinoma in a sentinel lymph node...
- Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases
Marco Ferreira
Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisboa, Portugal
Mod Pathol 21:201-7. 2008
....
- Trastuzumab administration associated with change in HER2 status
Shaheenah Dawood
Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Clin Breast Cancer 8:366-9. 2008
..We present the unusual case of a patient with HER2/neu-positive stage I breast cancer who, after receiving adjuvant trastuzumab, relapsed to develop HER2/neu-negative metastatic disease...
- Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Wei T Yang
The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX, 77030, USA
Breast Cancer Res Treat 109:417-26. 2008
..To describe the role of Positron Emission Tomography/Computed Tomography (PET/CT), Magnetic Resonance Imaging (MRI), sonography, and mammography in patients with inflammatory breast cancer (IBC)...
